Loading…
Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study
BACKGROUNDObservational studies report that obstructive sleep apnea (OSA) is associated with an increasingly remodeled atrial substrate in atrial fibrillation (AF). However, the impact of OSA management on the electrophysiologic substrate has not been evaluated. OBJECTIVESIn this study, the authors...
Saved in:
Published in: | JACC. Clinical electrophysiology 2022-07, Vol.8 (7), p.869-877 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 877 |
container_issue | 7 |
container_start_page | 869 |
container_title | JACC. Clinical electrophysiology |
container_volume | 8 |
creator | Nalliah, Chrishan J Wong, Geoffrey R Lee, Geoffrey Voskoboinik, Aleksandr Kee, Kirk Goldin, Jeremy Watts, Troy Linz, Dominik Parameswaran, Ramanathan Sugumar, Hariharan Prabhu, Sandeep McLellan, Alex Ling, Liang-Han Joseph, Stephen A Morton, Joseph B Kistler, Peter Sanders, Prashanthan Kalman, Jonathan M |
description | BACKGROUNDObservational studies report that obstructive sleep apnea (OSA) is associated with an increasingly remodeled atrial substrate in atrial fibrillation (AF). However, the impact of OSA management on the electrophysiologic substrate has not been evaluated. OBJECTIVESIn this study, the authors sought to determine the impact of OSA management on the atrial substrate in AF. METHODSWe recruited 24 consecutive patients referred for AF management with at least moderate OSA (apnea-hypopnea index [AHI] ≥15). Participants were randomized in a 1:1 ratio to commence continuous positive airway pressure (CPAP) or no therapy (n = 12 CPAP; n = 12 no CPAP). All participants underwent invasive electrophysiologic study (high-density right atrial mapping) at baseline and after a minimum of 6 months. Outcome variables were atrial voltage (mV), conduction velocity (m/s), atrial surface area |
doi_str_mv | 10.1016/j.jacep.2022.04.015 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2693777899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2693777899</sourcerecordid><originalsourceid>FETCH-LOGICAL-p103t-4e56ec4f08551ca45e984cb1ae3a5e87f6468337a4c247b73a98039310f115043</originalsourceid><addsrcrecordid>eNotjk1Lw0AURQdBsNT-AjezdJP45iszcRdCq4VCC6nrMhlfcEKaxMxE8N8b0dW9HDiXS8gDg5QBy57atLUOx5QD5ynIFJi6ISsuQSUKmLkjmxBagAVzw5lckXp_Ha2LdGhoeSpOdOhp_EBaxMnbju58Pfmus9EvvJrrECcbkfqeHn_77KL_Qlp1iCMtxh7tMz0vdnXYbk9JsaNVnN-_78ltY7uAm_9ck7fd9ly-Jofjy74sDsnIQMREosrQyQaMUsxZqTA30tXMorAKjW4ymRkhtJWOS11rYXMDIhcMGsYUSLEmj3-74zR8zhji5eqDw-V-j8McLjzLhdba5Ln4AZdQVto</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2693777899</pqid></control><display><type>article</type><title>Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study</title><source>ScienceDirect Journals</source><creator>Nalliah, Chrishan J ; Wong, Geoffrey R ; Lee, Geoffrey ; Voskoboinik, Aleksandr ; Kee, Kirk ; Goldin, Jeremy ; Watts, Troy ; Linz, Dominik ; Parameswaran, Ramanathan ; Sugumar, Hariharan ; Prabhu, Sandeep ; McLellan, Alex ; Ling, Liang-Han ; Joseph, Stephen A ; Morton, Joseph B ; Kistler, Peter ; Sanders, Prashanthan ; Kalman, Jonathan M</creator><creatorcontrib>Nalliah, Chrishan J ; Wong, Geoffrey R ; Lee, Geoffrey ; Voskoboinik, Aleksandr ; Kee, Kirk ; Goldin, Jeremy ; Watts, Troy ; Linz, Dominik ; Parameswaran, Ramanathan ; Sugumar, Hariharan ; Prabhu, Sandeep ; McLellan, Alex ; Ling, Liang-Han ; Joseph, Stephen A ; Morton, Joseph B ; Kistler, Peter ; Sanders, Prashanthan ; Kalman, Jonathan M</creatorcontrib><description>BACKGROUNDObservational studies report that obstructive sleep apnea (OSA) is associated with an increasingly remodeled atrial substrate in atrial fibrillation (AF). However, the impact of OSA management on the electrophysiologic substrate has not been evaluated. OBJECTIVESIn this study, the authors sought to determine the impact of OSA management on the atrial substrate in AF. METHODSWe recruited 24 consecutive patients referred for AF management with at least moderate OSA (apnea-hypopnea index [AHI] ≥15). Participants were randomized in a 1:1 ratio to commence continuous positive airway pressure (CPAP) or no therapy (n = 12 CPAP; n = 12 no CPAP). All participants underwent invasive electrophysiologic study (high-density right atrial mapping) at baseline and after a minimum of 6 months. Outcome variables were atrial voltage (mV), conduction velocity (m/s), atrial surface area <0.5 mV (%), proportion of complex points (%), and atrial effective refractory periods (ms). Change between groups over time was compared. RESULTSClinical characteristics and electrophysiologic parameters were similar between groups at baseline. Compliance with CPAP therapy was high (device usage: 79% ± 19%; mean usage/day: 268 ± 91 min) and resulted in significant AHI reduction (mean reduction: 31 ± 23 events/h). There were no differences in blood pressure or body mass index between groups over time. At follow-up, the CPAP group had faster conduction velocity (0.86 ± 0.16 m/s vs 0.69 ± 0.12 m/s; P (time × group) = 0.034), significantly higher voltages (2.30 ± 0.57 mV vs 1.94 ± 0.72 mV; P < 0.05), and lower proportion of complex points (8.87% ± 3.61% vs 11.93% ± 4.94%; P = 0.011) compared with the control group. CPAP therapy also resulted in a trend toward lower proportion of atrial surface area <0.5 mV (1.04% ± 1.41% vs 4.80% ± 5.12%; P = 0.065). CONCLUSIONSCPAP therapy results in reversal of atrial remodeling in AF and provides mechanistic evidence advocating for management of OSA in AF.</description><identifier>EISSN: 2405-5018</identifier><identifier>DOI: 10.1016/j.jacep.2022.04.015</identifier><language>eng</language><ispartof>JACC. Clinical electrophysiology, 2022-07, Vol.8 (7), p.869-877</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Nalliah, Chrishan J</creatorcontrib><creatorcontrib>Wong, Geoffrey R</creatorcontrib><creatorcontrib>Lee, Geoffrey</creatorcontrib><creatorcontrib>Voskoboinik, Aleksandr</creatorcontrib><creatorcontrib>Kee, Kirk</creatorcontrib><creatorcontrib>Goldin, Jeremy</creatorcontrib><creatorcontrib>Watts, Troy</creatorcontrib><creatorcontrib>Linz, Dominik</creatorcontrib><creatorcontrib>Parameswaran, Ramanathan</creatorcontrib><creatorcontrib>Sugumar, Hariharan</creatorcontrib><creatorcontrib>Prabhu, Sandeep</creatorcontrib><creatorcontrib>McLellan, Alex</creatorcontrib><creatorcontrib>Ling, Liang-Han</creatorcontrib><creatorcontrib>Joseph, Stephen A</creatorcontrib><creatorcontrib>Morton, Joseph B</creatorcontrib><creatorcontrib>Kistler, Peter</creatorcontrib><creatorcontrib>Sanders, Prashanthan</creatorcontrib><creatorcontrib>Kalman, Jonathan M</creatorcontrib><title>Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study</title><title>JACC. Clinical electrophysiology</title><description>BACKGROUNDObservational studies report that obstructive sleep apnea (OSA) is associated with an increasingly remodeled atrial substrate in atrial fibrillation (AF). However, the impact of OSA management on the electrophysiologic substrate has not been evaluated. OBJECTIVESIn this study, the authors sought to determine the impact of OSA management on the atrial substrate in AF. METHODSWe recruited 24 consecutive patients referred for AF management with at least moderate OSA (apnea-hypopnea index [AHI] ≥15). Participants were randomized in a 1:1 ratio to commence continuous positive airway pressure (CPAP) or no therapy (n = 12 CPAP; n = 12 no CPAP). All participants underwent invasive electrophysiologic study (high-density right atrial mapping) at baseline and after a minimum of 6 months. Outcome variables were atrial voltage (mV), conduction velocity (m/s), atrial surface area <0.5 mV (%), proportion of complex points (%), and atrial effective refractory periods (ms). Change between groups over time was compared. RESULTSClinical characteristics and electrophysiologic parameters were similar between groups at baseline. Compliance with CPAP therapy was high (device usage: 79% ± 19%; mean usage/day: 268 ± 91 min) and resulted in significant AHI reduction (mean reduction: 31 ± 23 events/h). There were no differences in blood pressure or body mass index between groups over time. At follow-up, the CPAP group had faster conduction velocity (0.86 ± 0.16 m/s vs 0.69 ± 0.12 m/s; P (time × group) = 0.034), significantly higher voltages (2.30 ± 0.57 mV vs 1.94 ± 0.72 mV; P < 0.05), and lower proportion of complex points (8.87% ± 3.61% vs 11.93% ± 4.94%; P = 0.011) compared with the control group. CPAP therapy also resulted in a trend toward lower proportion of atrial surface area <0.5 mV (1.04% ± 1.41% vs 4.80% ± 5.12%; P = 0.065). CONCLUSIONSCPAP therapy results in reversal of atrial remodeling in AF and provides mechanistic evidence advocating for management of OSA in AF.</description><issn>2405-5018</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotjk1Lw0AURQdBsNT-AjezdJP45iszcRdCq4VCC6nrMhlfcEKaxMxE8N8b0dW9HDiXS8gDg5QBy57atLUOx5QD5ynIFJi6ISsuQSUKmLkjmxBagAVzw5lckXp_Ha2LdGhoeSpOdOhp_EBaxMnbju58Pfmus9EvvJrrECcbkfqeHn_77KL_Qlp1iCMtxh7tMz0vdnXYbk9JsaNVnN-_78ltY7uAm_9ck7fd9ly-Jofjy74sDsnIQMREosrQyQaMUsxZqTA30tXMorAKjW4ymRkhtJWOS11rYXMDIhcMGsYUSLEmj3-74zR8zhji5eqDw-V-j8McLjzLhdba5Ln4AZdQVto</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Nalliah, Chrishan J</creator><creator>Wong, Geoffrey R</creator><creator>Lee, Geoffrey</creator><creator>Voskoboinik, Aleksandr</creator><creator>Kee, Kirk</creator><creator>Goldin, Jeremy</creator><creator>Watts, Troy</creator><creator>Linz, Dominik</creator><creator>Parameswaran, Ramanathan</creator><creator>Sugumar, Hariharan</creator><creator>Prabhu, Sandeep</creator><creator>McLellan, Alex</creator><creator>Ling, Liang-Han</creator><creator>Joseph, Stephen A</creator><creator>Morton, Joseph B</creator><creator>Kistler, Peter</creator><creator>Sanders, Prashanthan</creator><creator>Kalman, Jonathan M</creator><scope>7X8</scope></search><sort><creationdate>20220701</creationdate><title>Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study</title><author>Nalliah, Chrishan J ; Wong, Geoffrey R ; Lee, Geoffrey ; Voskoboinik, Aleksandr ; Kee, Kirk ; Goldin, Jeremy ; Watts, Troy ; Linz, Dominik ; Parameswaran, Ramanathan ; Sugumar, Hariharan ; Prabhu, Sandeep ; McLellan, Alex ; Ling, Liang-Han ; Joseph, Stephen A ; Morton, Joseph B ; Kistler, Peter ; Sanders, Prashanthan ; Kalman, Jonathan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p103t-4e56ec4f08551ca45e984cb1ae3a5e87f6468337a4c247b73a98039310f115043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nalliah, Chrishan J</creatorcontrib><creatorcontrib>Wong, Geoffrey R</creatorcontrib><creatorcontrib>Lee, Geoffrey</creatorcontrib><creatorcontrib>Voskoboinik, Aleksandr</creatorcontrib><creatorcontrib>Kee, Kirk</creatorcontrib><creatorcontrib>Goldin, Jeremy</creatorcontrib><creatorcontrib>Watts, Troy</creatorcontrib><creatorcontrib>Linz, Dominik</creatorcontrib><creatorcontrib>Parameswaran, Ramanathan</creatorcontrib><creatorcontrib>Sugumar, Hariharan</creatorcontrib><creatorcontrib>Prabhu, Sandeep</creatorcontrib><creatorcontrib>McLellan, Alex</creatorcontrib><creatorcontrib>Ling, Liang-Han</creatorcontrib><creatorcontrib>Joseph, Stephen A</creatorcontrib><creatorcontrib>Morton, Joseph B</creatorcontrib><creatorcontrib>Kistler, Peter</creatorcontrib><creatorcontrib>Sanders, Prashanthan</creatorcontrib><creatorcontrib>Kalman, Jonathan M</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>JACC. Clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nalliah, Chrishan J</au><au>Wong, Geoffrey R</au><au>Lee, Geoffrey</au><au>Voskoboinik, Aleksandr</au><au>Kee, Kirk</au><au>Goldin, Jeremy</au><au>Watts, Troy</au><au>Linz, Dominik</au><au>Parameswaran, Ramanathan</au><au>Sugumar, Hariharan</au><au>Prabhu, Sandeep</au><au>McLellan, Alex</au><au>Ling, Liang-Han</au><au>Joseph, Stephen A</au><au>Morton, Joseph B</au><au>Kistler, Peter</au><au>Sanders, Prashanthan</au><au>Kalman, Jonathan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study</atitle><jtitle>JACC. Clinical electrophysiology</jtitle><date>2022-07-01</date><risdate>2022</risdate><volume>8</volume><issue>7</issue><spage>869</spage><epage>877</epage><pages>869-877</pages><eissn>2405-5018</eissn><abstract>BACKGROUNDObservational studies report that obstructive sleep apnea (OSA) is associated with an increasingly remodeled atrial substrate in atrial fibrillation (AF). However, the impact of OSA management on the electrophysiologic substrate has not been evaluated. OBJECTIVESIn this study, the authors sought to determine the impact of OSA management on the atrial substrate in AF. METHODSWe recruited 24 consecutive patients referred for AF management with at least moderate OSA (apnea-hypopnea index [AHI] ≥15). Participants were randomized in a 1:1 ratio to commence continuous positive airway pressure (CPAP) or no therapy (n = 12 CPAP; n = 12 no CPAP). All participants underwent invasive electrophysiologic study (high-density right atrial mapping) at baseline and after a minimum of 6 months. Outcome variables were atrial voltage (mV), conduction velocity (m/s), atrial surface area <0.5 mV (%), proportion of complex points (%), and atrial effective refractory periods (ms). Change between groups over time was compared. RESULTSClinical characteristics and electrophysiologic parameters were similar between groups at baseline. Compliance with CPAP therapy was high (device usage: 79% ± 19%; mean usage/day: 268 ± 91 min) and resulted in significant AHI reduction (mean reduction: 31 ± 23 events/h). There were no differences in blood pressure or body mass index between groups over time. At follow-up, the CPAP group had faster conduction velocity (0.86 ± 0.16 m/s vs 0.69 ± 0.12 m/s; P (time × group) = 0.034), significantly higher voltages (2.30 ± 0.57 mV vs 1.94 ± 0.72 mV; P < 0.05), and lower proportion of complex points (8.87% ± 3.61% vs 11.93% ± 4.94%; P = 0.011) compared with the control group. CPAP therapy also resulted in a trend toward lower proportion of atrial surface area <0.5 mV (1.04% ± 1.41% vs 4.80% ± 5.12%; P = 0.065). CONCLUSIONSCPAP therapy results in reversal of atrial remodeling in AF and provides mechanistic evidence advocating for management of OSA in AF.</abstract><doi>10.1016/j.jacep.2022.04.015</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2405-5018 |
ispartof | JACC. Clinical electrophysiology, 2022-07, Vol.8 (7), p.869-877 |
issn | 2405-5018 |
language | eng |
recordid | cdi_proquest_miscellaneous_2693777899 |
source | ScienceDirect Journals |
title | Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20CPAP%20on%20the%20Atrial%20Fibrillation%20Substrate%20in%20Obstructive%20Sleep%20Apnea:%20The%20SLEEP-AF%20Study&rft.jtitle=JACC.%20Clinical%20electrophysiology&rft.au=Nalliah,%20Chrishan%20J&rft.date=2022-07-01&rft.volume=8&rft.issue=7&rft.spage=869&rft.epage=877&rft.pages=869-877&rft.eissn=2405-5018&rft_id=info:doi/10.1016/j.jacep.2022.04.015&rft_dat=%3Cproquest%3E2693777899%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p103t-4e56ec4f08551ca45e984cb1ae3a5e87f6468337a4c247b73a98039310f115043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2693777899&rft_id=info:pmid/&rfr_iscdi=true |